Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: A report of 3 cases and literature review
“Reporting from the medical technology front, Xiangya Hospital of Central South University has made significant strides in hepatic lymphoepithelioma-like carcinoma (LELC) research. The hospital has successfully treated three patients with EBV-associated LEL-CC, marking a new direction for the accurate diagnosis and treatment of this rare liver tumor.”
PENG Lushan, PENG Xianchu, DUAN Saili, ZHANG Zhejia. Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: A report of 3 cases and literature review[J]. Journal of Central South University. Medical Science, 2024, 49(2): 319-330.
PENG Lushan, PENG Xianchu, DUAN Saili, ZHANG Zhejia. Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma: A report of 3 cases and literature review[J]. Journal of Central South University. Medical Science, 2024, 49(2): 319-330. DOI:,10.11817/j.issn.1672-7347. 2024.230298
SPP2 plays a role in the tumorigenesis of hepatocellular carcinoma: A bioinformatic based analysis
Construction of web-based prediction nomogram models for cancer-specific survival in patients at stage IV of hepatocellular carcinoma depending on SEER database
Role of miR-5010-3p in predicting the prognosis of hepatocellular carcinoma
Effect of miRNA-200b on the proliferation of liver cancer cells via targeting SMYD2/p53 signaling pathway
MiR-5010-3p is a potential novel prognostic biomarker for hepatocellular carcinoma